Kevin Rakin's Net Worth

-$2.05 Million

Estimate Recalculated Apr 18, 2024 07:09PM EST

Who is Kevin Rakin?

Kevin Rakin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Omrix Biopharmaceuticals, Inc., GENAISSANCE PHARMACEUTICALS INC, HISTOGENICS CORP, ORAMED PHARMACEUTICALS INC., Quantum-Si Inc, ELUTIA INC., VION PHARMACEUTICALS INC, and CLINICAL DATA INC.

SEC CIK

Kevin Rakin's CIK is 0001184421

Past Insider Trading and Trends

2021 was Kevin Rakin's most active year for acquiring shares with 14 total transactions. Kevin Rakin's most active month to acquire stocks was the month of November. 2005 was Kevin Rakin's most active year for disposing of shares, totalling 11 transactions. Kevin Rakin's most active month to dispose stocks was the month of September. 2021 saw Kevin Rakin paying a total of $21,310,311.72 for 9,559,368 shares, this is the most they've acquired in one year. In 2021 Kevin Rakin cashed out on 131,329 shares for a total of $993,131.29, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Omrix Biopharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.00%
2K
—
—
6K
Sep 4
Form 4
+100.00%
2K
$13.65
$27,296.35
4K
Mar 26
Form 4
∞
2K
—
—
2K
May 31
Form 4
—
0
—
—
0
Jan 16
Form 3
—
0
—
—
0
No matching records found

GENAISSANCE PHARMACEUTICALS INC No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-684.09K
—
—
0
Oct 6
Form 4
+6.01%
35K
—
$35.00
617.09K
Jan 7
Form 4
-0.43%
-2.50K
—
—
582.09K
Feb 23 - Apr 27
Form 4
—
0
—
—
0
Dec 9
No matching records found

HISTOGENICS CORP (OCGN) Snapshot price: $0.5148

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+76.44%
350.85K
—
—
809.82K
Feb 8
Form 4
+1,559.77%
230.77K
—
—
245.56K
Oct 10
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 16
Form 4
+165.96%
142.4K
—
—
228.2K
Nov 30
Form 4
+70.17%
35.38K
$2.25
$79,607.25
85.8K
Sep 29
Form 4
—
0
—
—
0
Jun 24
Form 4
+51.81%
37.21K
$10.92
—
109.03K
Dec 8
Form 3
—
0
—
—
0
No matching records found

ORAMED PHARMACEUTICALS INC. (ORMP) Snapshot price: $2.8256

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.65%
-10.00K
$9.41
-$94,096.00
46.66K
Mar 21
Form 4
+6.90%
3.66K
$7.72
$5.30
56.66K
Feb 17
Form 4/A
-8.62%
-5.00K
—
—
53K
Feb 11
Form 4
-9.61%
-5.00K
—
—
47K
Feb 11
Form 4
+11.54%
6K
—
—
58K
Jan 3
Form 4
-8.77%
-5.00K
—
—
52K
Dec 16
Form 4
-27.02%
-21.10K
$20.99
-$442,829.92
57K
Sep 16
Form 4
+14.68%
10K
—
—
78.1K
Aug 31
Form 4
+352.19%
53.04K
$14.02
$13.95
68.1K
Aug 9
Form 4
—
0
—
—
0
Feb 17
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Apr 10 - Sep 12
Form 4
—
0
—
—
0
Apr 10
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Feb 9
Form 4
+59.19%
5.6K
$6.50
$36,427.87
15.06K
Dec 5 - Dec 6
Form 4
∞
9.46K
$6.18
$58,428.35
9.46K
Dec 1 - Dec 2
Form 3
—
0
—
—
0
No matching records found

Quantum-Si Inc (QSI) Snapshot price: $1.435

Chairman and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 12
Form 4
-33.37%
-601.00K
—
—
1.2M
Dec 20
Form 4
-4.71%
-89.00K
$2.15
-$191,234.30
1.8M
Dec 15
Form 4
—
0
—
—
0
May 11
Form 4
∞
1.92M
$10.00
$19,010,000.00
1.92M
Jun 10 - Jun 11
Form 3
—
0
—
—
0
No matching records found